Opus Genetics (IRD) FCF Margin (2020 - 2026)
Opus Genetics (IRD) reported FCF Margin of 590.03% for Q1 2026, down 38422.0% year-over-year from N/an in Q1 2025, and down 131.92% on a QoQ basis from 254.41% in Q4 2025.
Opus Genetics (IRD) has 7 years of FCF Margin data on file, last reported at 590.03% in Q1 2026.
- Quarterly FCF Margin fell 38422.0% year-over-year to 590.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 325.34% (down 11398.0% YoY) and the FY2025 annual result came in at 248.33%, down 1565.0% from the prior year.
- FCF Margin retreated to 590.03% in Q1 2026 per IRD's latest filing, from 254.41% in the prior quarter.
- Across five years, FCF Margin topped out at 268.95% in Q4 2023 and bottomed at 655.76% in Q2 2024.
- The 5-year median for FCF Margin is 202.89% (2025), against an average of 197.67%.
- The widest annual swing landed in 2024, when FCF Margin plunged 68267 bps; it then jumped 29944 bps in 2025.
- Tracing IRD's FCF Margin over 5 years: stood at 72.25% in 2022, then soared by 272 bps to 268.95% in 2023, then sank by 164 bps to 172.9% in 2024, then tumbled by 47 bps to 254.41% in 2025, then tumbled by 132 bps to 590.03% in 2026.
- Per Business Quant, the three latest IRD FCF Margin figures stand at 590.03% (Q1 2026), 254.41% (Q4 2025), and 199.97% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -590.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -590.03% |
| Dec 31, 2025 | -254.41% |
| Sep 30, 2025 | -199.97% |
| Jun 30, 2025 | -356.32% |
| Mar 31, 2025 | -205.81% |
| Dec 31, 2024 | -172.90% |
| Sep 30, 2024 | -132.66% |
| Jun 30, 2024 | -655.76% |
| Mar 31, 2024 | -334.07% |
| Dec 31, 2023 | 268.95% |
| Sep 30, 2023 | -25.16% |
| Jun 30, 2023 | 26.92% |
| Mar 31, 2023 | -208.46% |
| Dec 31, 2022 | 72.25% |
| Sep 30, 2021 | -732.92% |
| Jun 30, 2021 | -4,328.00% |
| Mar 31, 2020 | -63.65% |